Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure I could be mistaken, but the yahoo poster leroy44 seems to be the same as here; {"44" was the famous Leroy's number]; also my conclusion is based on the sum of his posts and clues I gleaned from his prior posts. Perhaps the poster is an admirer of this great player, but ..I am not sure it is legal to assume another real-person's identity on a MB.
My speculation Parents
Thank you leroy for being a loyal supporter of our company as well as an investor. You must post as leroy44 on yahoo; I just read your resume in Wikipedia...I did not realize we had a person of such great accomplishments posting here and on yahoo. I apologize for all my posts that were "caffeine" inspired. Sometimes the bashers just get under your skin.
Parents
Yes I will speculate [a repeat of my yahoo post]
There is another real possibility; an investor has a margin call on another stock,not NNLX, and had to sell or the broker would take control of his/her entire account.
Why do I consider this possibility - because:
No serious investor would sell at market [which I believed occurred]; but would sell gradually to protect the value of all of his shares. However, a margin call would make the difference. Just my view.
Parents
Mo....no one on this board has been critical of EMT....he is valued here.
Parents
Any comments on the specifics of the TMC studies with GBS or MRSA is pure speculation. The details will emerge with publication. However, I did hear the results were outstanding, and I am sure the methods will withstand any scrutiny. Procedures followed would conform to recognized standards; TMC is not going to waste time or money on fruitless studies. The doctors here have worked with out technology for months before clinical trials were approved and begun.
Parents
Regardless, there is no breach of conflict of interest rules here; and should have no impact on any impending submission for publication or FDA approval. I have studied "conflict of interest rules" rather extensively; family member do not always agree either...mine do not at present re a host of issues LOl
Parents
Incorrect; John Faro, MD., PhD., is doing the studies; Dr. Sebastian Faro is now on the SAB; no conflict of interest. Related, but family ties do not creat a conflict of interest in my view.
My understanding is that Dr. Sebastian Faro is one of the leading authorities in infectious diseases; our SAB has some of the top doctors in the world; my view
Parents
It is all smoke and mirrows johnny; the decision has been made and will not be altered so if unhappy, there are options for you.
Parents
I am not the queen of anything and we disagree here - as I stated previously, the last live SHM was miserable because of a lady and her private remarks were louder than the presenters. Were you there at the last SHM?; did you like the format? I have no intention of following Bret over a cliff; again the implication is erroneous; If you have followed NNLX since the hydrogen days, then why did not you attend the last SHM? With the format you prefer? Again there is a lot of support for the virtual SHM and good reasons for that as outlined by Rail...pros and cons well stated; let us see how this unfolds; the discussion is moot since the format has been decided; why talk it up more? You will not change any shareholders' opinion. Certainly not mine; I have viewed the website of Bridgeroad and am satisfied that our SHM will be excellent; yes I do look forward to more financials being released.
Parents
REALLY - Bret hero worship?; that is a little much; I support the virtual SHM because the last one [live] was miserable and there is a lot of expense beside renting a room - i.e. BOD airline tickets and hotels [for out of town BODs] AND other expenses. If you assume that Bret will skirt questions and you do not trust him, definitly this stock is not for you. I reflect a lot of shareholder sentiment so there is support for the virtual SHM from other shareholders. Thanks Rail...a balanced answer.
Parents
The reason for thr date change is thaat April 22 is Good Friday; hence a new date will be set.
Parents
And a new chapter in NNLX is beginning; the reuters interview is excellent because it covered not only our CEO's presentation, but also the TMC clinical trials [with Dr. Faro] giving validity to the technology and company. Plus the coverage of Reuters is global; it is showing up everywhere.
Parents
And a new chapter in NNLX is beginning; the reuters interview is excellent because it covered the TMC clinical trials giving validity to the technology and company\
Parents
Sorry for the delay; the private site is
http://nnlx.forumotion.com/login
Parents
Here is something on the web out today by an outside company.
hivelocitymedia.com/innovationnews/Nanologix1_27_11.a spx
www.hivelocitymedia.com
NanoLogix' new breakthroughs raise Hubbard company's public profile
Thursday, January 27, 2011
Related Tags
Biomedical, Cincinnati/Southwest Ohio
Cincinnati With a roster of patents ranging from medical diagnostics, stem-cell research and applied microbiology, NanoLogix has kept a low profile for much of its existence. Its new work, with ramifications for fields as far-reaching as homeland security to food safety, is about to change that for the Hubbard-based tech firm.
Begun more than 20 years ago as Infetech, ars the company for years focused on research and other endeavors, including alternative energy. But when CEO Bret Barhnizer came on board in 2007, he quickly saw the commercial potential for the company's work in diagnostic technology.
"We had years of work behind the scenes, developing pieces of the puzzle, but hadn't put all the pieces together," he says. "We recognized early on that the company wasn't monetizing its patents, not taking advantage of its expertise."
Re-christened NanoLogix in 2007, the company quickly refocused on rapid detection testing. Using membranes treated through new filtering and staining processes, its Ultra-Fast testing kits are designed to detect the presence of harmful microorganisms, looking for antibody-antigen reactions, in a fraction of the time as traditional petri dish tests.
In the case of anthrax, Nanologix's test delivered results in 2-6 hours, as opposed to the old standard of 24 hours. Its Y. pestis test — for bubonic plague — delivered in 24 hours, rather than 48 hours, the previous gold standard.
"We would go to exhibitions, and the scientists were enthralled by our technology," Barnhizer says.
While the kits continue third-party testing as a prelude to gaining FDA approval for use in other than scientific experiments, NanoLogix has already started reaping the rewards. Last year, it signed a multi-year contract with the U.S. Environmental Protection Agency to develop rapid testing for bacterial threats to drinking water.
The company has also built a 2,800-square foot manufacturing facility in Hubbard to will localize work being done elsewhere, from Cincinnati to Houston.
Source: Bret T. Barnhizer, NanoLogix
Writer: Dave Malaska
http://www.hivelocitymedia.com/innovatio...
I expect NNLX to receive the grant - not only is our technology revolutionary and essential in the medical field but Battelle Memorial is listed as the Collaborator and Battelle pretty much gets the grants it requests...in my view
Parents
Rail...do not understand; I have been wondering where you were and will try to contact you; usually if you leave a message, I will get it even if away from my computer. So let me try now
Parent
Actually, this is not a German company, but a Kuwaiti Company that markets German medical supplies as well as other supplies throughout the region; I got a clarification on that last night.
Parents
That post is one of your greatest and most informative; thanks for reposting it here
Parents
Thanks PDE - glad you are posting here; your last post was informative and appreciated.
Parents
Nano...not a chance that the yahoo bashers will survive here; yesterday, powerstock...'s post were deleted almost immediately by the I-Hub administrators; they got to it faster than even our board moderator who is likewise determined not to permit the yahoo basher-spammers from coming over to this board.
Parents
I am requesting your post be deleted as an effort to continue your mindless bashing from yahoo to this board where there is a moderator, in case you did not notice.
Parents...
In addition, the Battelle verification and study of the BNF. All of these studies are critical for future sales. Yes we wait longer than we expected but then, the marketing goal is achieved.
cashwealth,,,is not an excellent plan being now executed by the TMC clinical trials and the CRADA agreement with the EPA?...These are amazing developments for our company.
cashwealth; I believe NNLX thought that the Battelle paper would provide sufficient validation but it does not, being limited to anthrax. So the TMC studies are crucial for additional validation/certification/FDA approval. When these goals are achieved, sales will not be any problem at all. Our technology will be the "gold Standard of care" my view
Parents
masscommuter...you first must have validation of NNLX's diagnostic products before you can mass sell them; that is why the technologies, at this time, are sold for research only. That is what the TMC clinical trials are all about; getting the data that validates our tools; when that is accomplished, and reports are published, selling to a mass market will be easy. But the cart cannot be placed in front of the horse.
I answered cashwealth in a different manner if you did not read that post; our tech now is for research only meaning we are probably selling to Battelle and affliate research institutions; this also means we need further validation, certification, FDA approval for mass marketing. Sergey left for whatever reasons but no person is irreplaceable and apparently NNLX had a replacement on hand who showed his mettle by devising the quick test kits. Perhaps Sergey's contributions were complete and he had other sights in view; I really do not try and spin anything; just my view of things.
Parents
cashwealth = I must answer publicly because I am not a paying member of the I-Hub; production amounts have not been announced by the company, but the website states that orders are for "research only". This means NNLX is probably selling to Batelle and affiliate research facilities. Also I believe this means that our technologies must be validated or certified or FDA approved before mass marketing can begin in other arenas. The current research and the Texas Medical Center and other facilities will provide the data for achieving these other goals in my view; and for these goals to be achieved is usually a brief time-frame. This is not anywhere the difficult procedures followed for FDA approval for a drug. By the time of our shareholders' meeting in April 2011, NNLX SHOULD be well on its way towards these goals or will have already achieved them and will be mass marketing. I believe Bret chose the time of the shareholders' meeting wisely.
Parents
Yes Sergei is gone. But he has been replaced, and I am sure this is a positive for the company. I posted AKAPAK's analysis which I believe sums up the event. Previously posted here, a few posts ago. His work on the technologies was probably complete or he had other plans.
Parents
gobadgers...perhaps you misunderstood the post; the company is moving into production, not its research and development group; however, a review of the qualification of the new Director of R&D makes him more compatible with the company goals. And all moves into production are always supported by R&D; that is why they are there.
Parents
I reposted this post [yours] on Yahoo MB. Thought it was great and an accurate assessment of the situation
Parents thanks
From the website; an update
Internal Update
Wednesday, December 02, 2010
NanoLogix is extremely pleased to announce that Ahmer Kodvawala has been appointed Director of its Research and Product Development Laboratory in Cincinnati. Ahmer Kodvawala earned an MBA degree from the University of Cincinnati that included advanced work in Corporate Strategy, Project Management, and New Product Development. He also received a Master of Science degree in Medical Genetics at the University of Newcastle in the United Kingdom. While he was working in the NanoLogix lab since June 2010, it became clear that Ahmer brings a unique blend of experience, business expertise and research skills of a kind that were not available to the company with the laboratory staff as constituted. Management made the decision that the abilities offered by its new Director of Research and Development are vital to the company’s growth as NanoLogix moves into an exciting stage of product refinement and marketing.
Reasons for this strategic decision include the fact that Ahmer Kodvawala has proved to be a meticulous scientist with experience in molecular biology and diagnostics in addition to his strong management and marketing skills gained through Cincinnati’s MBA program and his entrepreneurial experience in a start-up bio-consulting firm. He possesses the ability to facilitate effective team work with colleagues and has demonstrated multi-tasking skills in complex cross cultural environments. During his career he has coordinated research projects on lipid metabolism and pathophysiology of atherosclerosis, generated and characterized a cholesterol esterase lipase transgenic mouse which significantly advanced technical understanding of the enzyme’s role in atherosclerosis, and led a National Institute of Health (NIH) RO1 grant to study lipoprotein complications of HIV infection and HIV therapy. He is the author or coauthor of multiple scientific papers.
________________________________________
Contact:
NanoLogix, Inc.
Investor Relations
Carol Surrena
Telephone: 330-534-0800
E-mail: carol@nanologix.com
Parents
I believe mass....that the companies NNLX is working with restrict the release of information. My understanding only
Parents
cash....it was so long ago. I am also a member of a private forum of vetted longs and, as I recall, some posts may be there. But they were also posted on yahoo; I regret that I did not copy/paste them here.
Parents
cashwealth....you must have been away for a long time Yes the clean room is finished; several investors have visited and have given glowing reports...that is old news LOL Have a great day
And I believe we are in production to a certain level although no news has been released by the company
Parents
grateful that you are back as our moderator thanks
NEOhioinvestor...why does it say above "no moderator"? Aren't you our moderator? Is there a mistake?
Sensing the reversal, we have a buy order in...lol
Great company, great investment Parents
This is so funny from yahoo
The NNLX animals [of the yahoo message board]
The skunk: SGSF70. He comes around to make a stink but is a furry little guy.
The black Lab: LOCKSHED..Loyal dog. Someone you want on your side and dumb enough to run through a wall for you.
The giraffe: WARFIELD.. Sees things from a different perspective
The OLD tiger: COLTATT.. Fighter, but best days are behind him
The MULE: true. Need I say more.
The turtle: TRACEMAN Slow and steady. Consistant.
The ant: JIMMINY. Just a little guy. A follower, not a leader.
The chicken: Nanoxinvstor. The sky is falling the sky is falling. Mr. Redactor
The parrot: OMar, office, ambig etc. King of copy and paste
The Rhino: PARENTS. Thick skinned. Strength.
The black Bear: SONGBIRD. Only post once in a while then goes back to hibernation.
The FOX: Who else---LEAWOOD! :) Foxey, cute and cuddily.
Wile E Coyote: PetroDriller-- Smart guy, but usually done in by his own words. Rambles too much.
The alley CAT: Badbilly-- Seemingly full of you know what and vinegar and up to battle whoever.
Have fun and a great day.
Hope you all enjoyed this Parents
For your encouragement and entertainment, I suggest viewing the movie "Secretariat" - this true story is far more than a "horse story"; it is an American Saga. I have the same confidence in NNLX as Penny McTweedy Chernery had in Secretariat from the time of the colt's birth. A riveting account with a rather surprise ending. The people who saw the film on my recommendation were exceedingly pleased,
Parents